Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver:: Consequences for enzyme expression and busulfan conjugation

被引:67
作者
Bredschneider, M
Klein, K
Mürdter, TE
Marx, C
Eichelbaum, M
Nüssler, AK
Neuhaus, P
Zanger, UM
Schwab, M
机构
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany
[2] Humboldt Univ, Charite, Dept Surg, Berlin, Germany
关键词
D O I
10.1067/mcp.2002.124518
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: High-dose busulfan is widely used as part of conditioning regimens for patients who are undergoing hematopoietic stem cell or bone marrow transplantation. High plasma concentrations of busulfan have been linked to the occurrence of hepatic venoocclusive disease (VOD), a severe complication associated with a high mortality. Because conjugation with glutathione, the major route of biotransformation of busulfan, is predominantly catalyzed by the isozyme glutathione S-transferase A1 (GSTA1), we hypothesized that low expression or function of GSTA1 in liver caused by genetic polymorphisms may be the mechanism underlying VOD. Methods. Immunoblot analysis of GSTA and measurement of busulfan-glutathione conjugation by liquid chromatography-mass spectrometry were performed in 48 normal human liver samples. To search for polymorphisms, the complete GSTA1 coding regions and the promoter fragment were sequenced. All results were compared by multivariate analysis. Results. Absolute levels of GSTA protein and formation rates of busulfan-glutathione conjugate displayed a 7- and 8-fold range, from 240 to 1600 pmol/mg and 25 to 205 pmol/min per milligram of total cytosolic protein, respectively, and correlate (r(2) = 0.49, P<.0001). A total of 8 single nucleotide polymorphisms (SNPs) of GSTA1 were identified, 1 of which was a silent mutation in exon 5 (A375G); all others were found in the promoter region. Haplotype analysis revealed the existence of 5 defined alleles. There was no significant relationship between any of the GSTA1 SNPs or haplotypes and either hepatic glutathione S-transferase A (GSTA) expression or GSTA1 function. Conclusions: The identified GSTA1 polymorphisms are not likely to be related to the VOD because they do not appear to be associated with changes in GSTA expression or function. Compared with other members of the GST family, GSTA1 displays surprisingly little variation.
引用
收藏
页码:479 / 487
页数:9
相关论文
共 40 条
[1]  
Baron F, 1997, HAEMATOLOGICA, V82, P718
[2]   Veno-occlusive disease of the liver [J].
Bearman, SI .
CURRENT OPINION IN ONCOLOGY, 2000, 12 (02) :103-109
[3]   Characterization and chromosome location of the gene GSTZ1 encoding the human Zeta class glutathione transferase and maleylacetoacetate isomerase [J].
Blackburn, AC ;
Woollatt, E ;
Sutherland, GR ;
Board, PG .
CYTOGENETICS AND CELL GENETICS, 1998, 83 (1-2) :109-114
[4]   Identification, characterization, and crystal structure of the omega class glutathione transferases [J].
Board, PG ;
Coggan, M ;
Chelvanayagam, G ;
Easteal, S ;
Jermiin, LS ;
Schulte, GK ;
Danley, DE ;
Hoth, LR ;
Griffor, MC ;
Kamath, AV ;
Rosner, MH ;
Chrunyk, BA ;
Perregaux, DE ;
Gabel, CA ;
Geoghegan, KF ;
Pandit, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (32) :24798-24806
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   FREQUENCY OF VENOOCCLUSIVE DISEASE OF THE LIVER IN BONE-MARROW TRANSPLANTATION WITH A MODIFIED BUSULFAN CYCLOPHOSPHAMIDE PREPARATIVE REGIMEN [J].
BRODSKY, R ;
TOPOLSKY, D ;
CRILLEY, P ;
BULOVA, S ;
BRODSKY, I .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (03) :221-225
[7]  
Czwerwinski M, 1996, DRUG METAB DISPOS, V24, P1015
[8]   Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes [J].
DeLeve, LD ;
Wang, XD .
PHARMACOLOGY, 2000, 60 (03) :143-154
[9]   Glutathione defense in non-parenchymal cells [J].
Deleve, LD .
SEMINARS IN LIVER DISEASE, 1998, 18 (04) :403-413
[10]  
Dix SP, 1996, BONE MARROW TRANSPL, V17, P225